Actively Recruiting
Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America
Led by University of Alabama at Birmingham · Updated on 2026-03-12
1000
Participants Needed
15
Research Sites
69 weeks
Total Duration
On this page
Sponsors
U
University of Alabama at Birmingham
Lead Sponsor
V
Vantive Health LLC
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is an international, multicenter, observational study aimed at investigating acute kidney injury requiring renal replacement therapy (AKI-RRT) in Latin American countries. The main questions this study aims to answer are: * What is the epidemiology, outcomes, and processes of care for patients with AKI-RRT in Latin America? * How do outcomes differ across different countries in Latin America? * What factors (demographics, clinical, socioeconomic) influence outcomes in patients with AKI-RRT in Latin America? The main aims of this study are to: * Establish a comprehensive database containing clinical, laboratory, treatment, process, and outcome data of patients with AKI-RRT in Latin America * Describe current epidemiology of AKI-RRT in Latin America * Compare processes of care and outcomes across different countries in Latin America * Provide data resources to facilitate and promote clinical research in AKI-RRT
CONDITIONS
Official Title
Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patient (≥18) admitted to the ICU
- First ICU admission during current hospitalization
- Diagnosis of acute kidney injury stage 3 according to KDIGO guidelines
- Renal replacement therapy started no earlier than 3 days before or no later than 7 days after ICU admission
You will not qualify if you...
- Transfer from outside hospital with ongoing renal replacement therapy
- Renal replacement therapy exposure of less than 2 days if continuous renal replacement therapy or peritoneal dialysis was provided, or less than 2 hemodialysis/slow low-efficiency dialysis sessions
- Patients with kidney failure on maintenance dialysis
- Kidney transplant recipients
- Previous or new diagnosis of glomerulonephritis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 15 locations
1
Hospital Obrero No 2
Cochabamba, Bolivia
Actively Recruiting
2
Ana Nery Hospital
Bahia, Brazil
Not Yet Recruiting
3
Hospital Sao Lucas da PUCRS
Porto Alegre, Brazil
Not Yet Recruiting
4
Hospital das Clínicas da Universidade de São Paulo
São Paulo, Brazil
Not Yet Recruiting
5
Hospital Las Higueras
Talcahuano, Chile
Not Yet Recruiting
6
Fundación Cardioinfantil
Bogotá, Colombia
Actively Recruiting
7
Hospital San Jose de Popayan
Popayán, Colombia
Actively Recruiting
8
Hospital General de la Plaza de la Salud
Santo Domingo, Dominican Republic
Actively Recruiting
9
DIALNEF
Quito, Ecuador
Not Yet Recruiting
10
Instituto Guatemalteco de Seguridad Social
Guatemala City, Guatemala
Not Yet Recruiting
11
Hospital Civil de Guadalajara
Guadalajara, Mexico
Actively Recruiting
12
Hospital General de México Dr Eduardo Liceaga
Mexico City, Mexico
Not Yet Recruiting
13
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Mexico City, Mexico
Actively Recruiting
14
Hospital Universitario "José Eleuterio González"
Monterrey, Mexico
Actively Recruiting
15
Hospital Nacional Arzobispo Loayza
Lima, Peru
Actively Recruiting
Research Team
J
Javier A Neyra, MD, MSCS
CONTACT
P
Patricia J Busta Flores
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here